Kuehnert Matthew J, Hill Holly A, Kupronis Benjamin A, Tokars Jerome I, Solomon Steven L, Jernigan Daniel B
Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA.
Emerg Infect Dis. 2005 Jun;11(6):868-72. doi: 10.3201/eid1106.040831.
Methicillin-resistant Staphylococcus aureus (MRSA) is increasingly a cause of nosocomial and community-onset infection with unknown national scope and magnitude. We used the National Hospital Discharge Survey to calculate the number of US hospital discharges listing S. aureus-specific diagnoses, defined as those having at least 1 International Classification of Diseases (ICD)-9 code specific for S. aureus infection. The number of hospital discharges listing S. aureus-specific diagnoses was multiplied by the proportion of methicillin resistance for each corresponding infection site to determine the number of MRSA infections. From 1999 to 2000, an estimated 125,969 hospitalizations with a diagnosis of MRSA infection occurred annually, including 31,440 for septicemia, 29,823 for pneumonia, and 64,706 for other infections, accounting for 3.95 per 1,000 hospital discharges. The method used in our analysis may provide a simple way to assess trends of the magnitude of MRSA infection nationally.
耐甲氧西林金黄色葡萄球菌(MRSA)日益成为医院感染和社区感染的病因,其在全国范围内的规模和严重程度尚不清楚。我们利用国家医院出院调查来计算美国列出金黄色葡萄球菌特异性诊断的医院出院人数,这些诊断定义为至少有1个国际疾病分类(ICD)-9代码明确针对金黄色葡萄球菌感染。列出金黄色葡萄球菌特异性诊断的医院出院人数乘以每个相应感染部位的耐甲氧西林比例,以确定MRSA感染的数量。1999年至2000年期间,估计每年有125,969例住院患者被诊断为MRSA感染,其中败血症31,440例,肺炎29,823例,其他感染64,706例,占每1000例医院出院人数的3.95。我们分析中使用的方法可能为评估全国范围内MRSA感染规模的趋势提供一种简单的方法。